title: Reply from Authors re: Steven A. Kaplan. Tadalafil for the Treatment of Benign Prostatic Hyperplasia: When the Moment Does Not Add Up. Eur Urol 2013;63:517-8: Tadalafil in the Treatment of Men with Lower Urinary Tract Symptoms and/or Erectile Dysfunction Symptoms.
authors.affiliation: Neuro-uro-andrology Department of Physical Medicine and Rehabilitation, Raymond Poincaré Academic Hospital, Versailles Saint Quentin en Yvelines University, Garches, France. Electronic address: giuliano@cyber-sante.org.
authors.forename: François
authors.initials: F
authors.lastname: Giuliano
authors.forename: Lars
authors.initials: L
authors.lastname: Viktrup
mesh_terms: D002243:Carbolines / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use*; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D000068581:Tadalafil; D016896:Treatment Outcome
chemical_list: D002243:Carbolines; D058986:Phosphodiesterase 5 Inhibitors; D000068581:Tadalafil